SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
- Andrew P. Hederman
- , Harini Natarajan
- , Leo Heyndrickx
- , Kevin K. Ariën
- , Joshua A. Wiener
- , Peter F. Wright
- , Evan M. Bloch
- , Aaron A.R. Tobian
- , Andrew D. Redd
- , Joel N. Blankson
- , Amihai Rottenstreich
- , Gila Zarbiv
- , Dana Wolf
- , Tessa Goetghebuer
- , Arnaud Marchant
- , Margaret E. Ackerman
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations